GKB Ophthalmics share news, announcements and annual reports
NSE: GKBBSE: 533212Healthcare Equipment & SuppliesSmall Cap
GKB Ophthalmics Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary
Last close ₹60.01down ₹0.49 (0.81%)BSE ₹59.00
Share price at the NSE close on 29 Oct 2026. Previous close ₹60.50.
29 Oct: open ₹59.80, high ₹62.80, low ₹56.13
52-week range of BSE trades to 29 Oct 2026
₹45.25Low, 5 Dec 2025₹76.90High, 15 Apr 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹30 Cr3,821st largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 9.33
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹1.49 crore of one-off items, the largest of them in the quarter to Mar 2026.
- 6.38
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 0.57
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 6.2%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹1.49 crore of one-off items, the largest of them in the quarter to Mar 2026.
- 9.0%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 10.5%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.21
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 1,78558.9% delivered
GKB Ophthalmics board and management
21 filed, newest first.
Jan 2026
May 2024
Mar 2024
19 Mar · Management
Jun 2023
May 2023
Apr 2019
Sep 2018
Jun 2014
3 Jun · Management
May 2013
29 May · Management
22 May · Management
An Additional Independent Director is expected to be inducted in the forthcoming Board of Directors' Meeting to be held on 24th May 2013. (Source MSE)
Feb 2013
14 Feb · Management
Mr. Somnath Sinai Priolkar has resigned from the Board of Directors of the Company and the Board has accepted the resignation of Mr. Somnath Sinai Priolkar, an Independent Director, with immediate effect. (Source MSE)14 Feb · Management
Resignation of Director
Feb 2012
14 Feb · Management
Board of Directors of the company in its meeting held on February 13, 2012, inter alia, has passed a resolution for re-appointment of Mr. K. G.Gupta as Managing Director of the Company for a period of 3 years effective from April 01, 2012. (Source MSE)14 Feb · Management
Reappointment
Mar 2011
31 Mar · Management
Mr. Joseph A.A. Dcosta has been appointed as additional Non Executive Independent Director w.e,f March 31, 2011.
Sep 2010
1 Sep · Management
Mr. Clifford Viegas has resigned as Independent Director with effect from August 31, 2010 (Source MSE)
Aug 2010
31 Aug · Management
Mr. Clifford Viegas, has resigned as Independent Director w.e.f. August 31, 2010.
May 2010
27 May · Management
Mr. Anil Vithal Palekar, Mr. Clifford Viegas and Mr. Sadashiv Sheth have been appointed as additional Non Executive Independent Dirctors. (Source MSE)
Apr 2010
28 Apr · Management
Mr. R.K. Gupta, Director, has resinged from the Board of Directors with effect from 19-09-2009 and Mr. B.K. Gupta, Director has ceased to the Director at the conclusion of the Annual General Meeting held on 19-09-2009. (Source MSE)